These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16197523

  • 1. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
    Georges F, Caillé S, Vouillac C, Le Moine C, Stinus L.
    Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
    [Abstract] [Full Text] [Related]

  • 2. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors.
    Georges F, Aston-Jones G.
    Neuropsychopharmacology; 2003 Jun; 28(6):1140-9. PubMed ID: 12700697
    [Abstract] [Full Text] [Related]

  • 3. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [Abstract] [Full Text] [Related]

  • 4. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L, Cador M, Zorrilla EP, Koob GF.
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [Abstract] [Full Text] [Related]

  • 5. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.
    Schulteis G, Stinus L, Risbrough VB, Koob GF.
    Neuropsychopharmacology; 1998 Nov; 19(5):406-16. PubMed ID: 9778662
    [Abstract] [Full Text] [Related]

  • 6. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
    Streel E, Dan B, Campanella S, Meyvaert A, Hanak C, Pelc I, Verbanck P.
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
    [Abstract] [Full Text] [Related]

  • 7. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y.
    Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717
    [Abstract] [Full Text] [Related]

  • 8. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR, Jones BC, Schulteis G.
    Psychopharmacology (Berl); 2003 Oct 03; 170(1):42-50. PubMed ID: 12783156
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
    Caillé S, Stinus L, Espejo EF, De Deurwaerdère P, Spampinato U, Koob GF.
    Neuropsychopharmacology; 2003 Feb 03; 28(2):276-83. PubMed ID: 12589380
    [Abstract] [Full Text] [Related]

  • 10. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
    Kosten TA.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):59-63. PubMed ID: 8206117
    [Abstract] [Full Text] [Related]

  • 11. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice.
    Shoblock JR, Maidment NT.
    Neuropsychopharmacology; 2006 Jan 11; 31(1):171-7. PubMed ID: 15956992
    [Abstract] [Full Text] [Related]

  • 12. Effects of two alpha 2 agonists, rilmenidine and clonidine, on the morphine withdrawal syndrome and their potential addictive properties in rats.
    Tierney C, Nadaud D, Koenig-Berard E, Stinus L.
    Am J Cardiol; 1988 Feb 24; 61(7):35D-38D. PubMed ID: 2894155
    [Abstract] [Full Text] [Related]

  • 13. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M.
    Psychopharmacology (Berl); 2003 Oct 24; 170(1):80-8. PubMed ID: 12768272
    [Abstract] [Full Text] [Related]

  • 14. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S, Espejo EF, Koob GF, Stinus L.
    Pharmacol Biochem Behav; 2002 Jul 24; 72(4):979-86. PubMed ID: 12062589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
    Taylor JR, Punch LJ, Elsworth JD.
    Psychopharmacology (Berl); 1998 Jul 24; 138(2):133-42. PubMed ID: 9718282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A, Trivulzio S.
    J Pharmacol Toxicol Methods; 1997 Nov 24; 38(3):117-31. PubMed ID: 9523765
    [Abstract] [Full Text] [Related]

  • 20. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Jin C, Araki H, Kawasaki Y, Nagata M, Suemaru K, Shibata K, Hamamura T, Kawasaki H, Gomita Y.
    Brain Res; 2006 Jan 19; 1069(1):120-6. PubMed ID: 16360647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.